These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23686603)

  • 21. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.
    Matlala M; Gous AG; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1273-1280. PubMed ID: 28776442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Writing meeting minutes for a pharmacy and therapeutics committee and its subcommittees.
    Anagnostis E
    Am J Health Syst Pharm; 2015 Jan; 72(2):95-6, 98-9. PubMed ID: 25550131
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of pharmacoeconomic data in making hospital formulary decisions.
    Odedina FT; Sullivan J; Nash R; Clemmons CD
    Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality control of hospital formularies.
    Rucker TD
    Pharm Weekbl Sci; 1988 Aug; 10(4):145-50. PubMed ID: 3174366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the Training, Responsibilities, and Practices of P&T Committee Members and Nonmember Contributors.
    Rodriguez R; Kelly BJ; Moody M
    J Manag Care Spec Pharm; 2017 Aug; 23(8):868-874. PubMed ID: 28737984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulary compliance and pharmacy labor costs associated with systematic formulary management strategy.
    Helmons PJ; Kosterink JG; Daniels CE
    Am J Health Syst Pharm; 2014 Mar; 71(5):407-15. PubMed ID: 24534596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ohio hospital formularies: an analysis of structure, process, and outcome.
    Parrish RH; Berger BA
    Hosp Pharm; 1985 Aug; 20(8):600-3, 606-11. PubMed ID: 10289647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contemporary challenges and novel strategies for health-system formulary management.
    Heindel GA; McIntyre CM
    Am J Health Syst Pharm; 2018 Apr; 75(8):556-560. PubMed ID: 29626005
    [No Abstract]   [Full Text] [Related]  

  • 29. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug formulary decision-making: Ethnographic study of 3 pharmacy and therapeutics committees.
    Schiff GD; Tripathi JB; Galanter W; Paek JL; Pontikes P; Fanikos J; Matta L; Lambert BL
    Am J Health Syst Pharm; 2019 Apr; 76(8):537-542. PubMed ID: 30915453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Models of hospital drug policy in the UK.
    Cotter SM; McKee M
    J Health Serv Res Policy; 1997 Jul; 2(3):144-53. PubMed ID: 10180375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cephalosporin-use restrictions in teaching hospitals.
    McCloskey WW; Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulary management as a tool to improve medication use and gain physician support.
    Lehmann DF; Guharoy R; Page N; Hirschman K; Ploutz-Snyder R; Medicis J
    Am J Health Syst Pharm; 2007 Mar; 64(5):464-6. PubMed ID: 17322158
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organization and operation of P & T Committees in the state of Florida: a survey.
    Hatton RC; Doering PL
    Hosp Formul; 1990 Sep; 25(9):983-6, 988-9. PubMed ID: 10106259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion of innovation II: Formulary acceptance rates of new drugs in teaching and non-teaching British Columbia hospitals--a drug development perspective.
    D'Sa MM; Hill DS; Stratton TP
    Can J Hosp Pharm; 1995 Feb; 48(1):7-15. PubMed ID: 10141063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and maintenance of an online formulary for a large health system.
    Sears EL
    Am J Health Syst Pharm; 2008 Mar; 65(6):510, 512. PubMed ID: 18319495
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacist recognition of and adherence to medication-use policies and safety practices.
    Saad AH; Sweet BV; Stumpf JL; Gruppen L; Oh M; Stevenson JG
    Am J Health Syst Pharm; 2007 Oct; 64(19):2050-4. PubMed ID: 17893416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.